Clinical Trial Update: Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness [NA]

View source ↗

Summary

A clinical trial evaluating the safety and performance of the CorNeat KPro for corneal blindness is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Disease
• Corneal Injuries
• Corneal Opacity

Drugs mentioned

• CorNeat KPro

Snippet

Sponsor: CorNeat Vision Ltd. | Conditions: Corneal Disease, Corneal Opacity | NA | Status: SUSPENDED